Description
Beta-CrossLaps (β-CrossLaps) is a biomarker used to assess bone metabolism, primarily indicating the degradation products of mature type I collagen during bone resorption. It is crucial in the diagnosis and treatment monitoring of osteoporosis. Beta-CrossLaps is extensively utilized for the early detection and management of this condition. Research indicates a negative correlation between Beta-CrossLaps levels and bone mineral density (BMD)-as BMD decreases, Beta-CrossLaps levels rise. Additionally, Beta-CrossLaps is correlated with other bone metabolism markers, such as osteocalcin. Its involvement in human bone diseases highlights its potential application in research on bone resorption and metabolism